Fourth Dimension Wealth, LLC
Position in JANX — Janux Therapeutics, Inc.
CIK 2056691
MIDDLEBURG HEIGHTS, OH
Position in JANX
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$9,216
+$876 QoQ
Shares Held
600
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#158
of 196 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fourth Dimension Wealth, LLC holds $59,831 across 9 Biotechnology names. JANX ranks #2 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
180 | $20,404 | |
| 2 | JANX |
Janux Therapeutics, Inc.
This page
|
600 | $9,216 | |
| 3 | INSM |
INSMED Inc
|
80 | $8,529 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11 | $6,858 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
22 | $6,622 | |
| 6 | MDXG |
Mimedx Group, Inc.
|
700 | $2,695 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
10 | $2,409 | |
| 8 | KYTX |
Kyverna Therapeutics, Inc.
|
250 | $2,227 |
All Filings in JANX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,216 | 600 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $8,340 | 600 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,140 | 300 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $7,332 | 300 | Shares | Sole | 2025-11-04 | |
| No filing history on record for this holder in this stock. | ||||||